Inter-individual

PENG Y s, PENG Y M, MCGEE D L and ALBERTS D s (1994) Carotenoids, tocopherols and retinoids in human buccal mucosal cells intra- and inter-individual variability and storage stability. J Clin Nutr 59(3) 636-43. 

NOAEL (no-observed-adverse-effect level) is defined as the highest dose at which no adverse effects are observed in the most susceptible animal species. The NOAEL is used as a basis for setting human safety standards for acceptable daily intakes (ADIs), taking into account uncertainty factors for extrapolation from animals to humans and inter-individual variabilities of humans. The adequacy of any margin of safety or margin of exposure must consider the nature and quality of the available hazard identification and dose-response data and the reliability and relevance of the exposure estimations. In some cases, no adverse endpoint can be identified such as for many naturally occurring compounds that are widespread in foods. In that case, an ADI Not Specified is assigned. ... 

The chemoreceptive mechanisms in amphibia are undoubtedly worthy of further analysis, not only for their own sake, but to provide clues as to the origination of advanced chemosignal systems. As noted above, a pheromonal signal from the mental gland acts as a courtship/ receptivity inducer. The plethodontid receptivity factor (PRF) (Chap. 3) despite its size (22 kD), seems to have been converted from its internal role as an inter-cellular cytokine, to an inter-individual coordinator of reproductive activity (Rollmann et al., 1999). Endocrine or... 

CYP2C19 is another example of the existence of both cross-ethnic and inter-individual variations in drug metabolism. This enzyme is involved in the metabolism of many psychotropics such as diazepam and tertiary tricyclic antidepressants, as well as one of the selective serotonin re-uptake inhibitors (SSRIs), citalopram. Using S-mephenytoin as the probe, previous studies showed that up to 20% of East Asians (Chinese, Japanese, and Koreans) are PMs, when only 3-5%... 

As is apparent from the literature reviewed above, that culture and ethnicity are powerful determinants of an individual s response to psychopharmacotherapy. Progress in this regard will vastly improve our current practice in using medications. However, it is necessary to remember that there are often very substantial inter-individual variations within any defined cultural or ethnic group, and that ethnic variations in pharmacological responses should not be interpreted stereotypically. 

With respect to other ethnic groups, African Americans may have a differential sensitivity to weight gain on clozapine (de Leon etal, 2007). They may also require lower doses than Caucasians (Kelly et al, 2006) and inter-individual as well as ethnic responsiveness maybe partly explained by differences in dopamine receptor polymorphisms (Hwang et al, 2005). It is conceivable that side effects may also be differentially expressed based on pharmacodynamic differences resulting from polymorphisms in other receptor types (histaminergic, muscarinic, etc.). This area remains largely unexplored with respect to ethnic differences in antipsychotic side effects. 

Ethnic differences have been shown to influence response to psychotropic medications. Much of the focus on the explanation for such differences has been on drug-metabolizing (CYP) enzymes of the liver and their sway over pharmacokinetic factors. It is now well recognized that differences in the distribution of polymorphic variants of CYP enzymes exist between different ethnic groups. However, within ethnic groups there are considerable inter-individual variations in drug kinetics, which may not be accounted for solely by genetic variation. Responses to pharmacotherapy are multifaceted and involve the interaction of environmental and... 

Levels of ACHE and PCHE vary in healthy people because of genetic differences or under specific physio-pathological conditions inter-individual coefficients of variation of cholinesterase activity have been determined to be about 15 to 25% for PCHE and 10 to 18% for RBC-ACHE. Corresponding figures for intra-individual variations are 6% and 3 to 7%, respectively (Dillon and Ho, 1987). 

Some OP compounds induce delayed neurotoxic effects ("delayed neuropathy") after acute poisoning. This delayed neurotoxic action is independent of cholinesterase inhibition but related to phosphorylation of a specific esterasic enzyme in the nervous tissue, called "neurotoxic esterase" or "neuropathy target esterase" (NTE) (Johnson, 1982). NTE is present in the nervous tissue, liver lymphocytes, platelets, and other tissues, but its physiological function is unknown. There is a rather large inter-individual variation of lymphocyte and platelet NTE activity (Table 2). 

Bonithon-Kopp C, Huel G, Grasmick C, et al. 1986c. Effects of pregnancy on the inter-individual variations in blood lead levels of lead, cadmium and mercury. Biol Res Preg 7 37-42. 

Heusler-Bitschv S, Knutti R, Schiatter C. 1988. Inter-individual variability of the kinetics of lead in man. In Braetter P, Schramel P, eds. Proceedings of the International Workshop Trace element analytical chemistry in medicine and biology. Vol. 5. April 1988, Neuherberg, West Germany, 627-634. 

---